FDA decision: Tozorakimab by AstraZeneca (on or before March 31, 2027)
K 0 contracts
1
1
FDA decision: Tozorakimab by AstraZeneca (on or before March 31, 2027)
K 0 contracts
1
1
Current odds
Snapshot from
As of Oct 29, 2026, 12:00 AM UTC, the highest-priced outcome on Kalshi is a full approval or an accelerated approval at 50%.
Kalshi
- a full approval or an accelerated approval50%
Yes prices. They are not order quotes; check each platform's rules, fees and live prices before trading.
AI Analysis
Trader mode: Market mechanics, assumptions and risks
K 0 contracts
Reported volume · provider units
1
Saved contracts
0
Same-question pairs
Source snapshot: Oct 29, 2026, 12:00 AM UTC
About This Event
FDA decision on Tozorakimab on or before March 31, 2027 If the FDA's decision on Tozorakimab by AstraZeneca on or before March 31, 2027 is a full approval or an accelerated approval, the market resolves to Yes. This market will resolve to No if the FDA's decision is a denial (CRL issued), a withdrawal by the sponsor, or a conditional approval — or if no decision is issued. This market will close early if the FDA issues a decision on Tozorakimab before Apr 1, 2027
AI-generated analysis based on market data. Not financial advice.
AI-written background. References identify the evidence used; Wikipedia links under Learn More are additional reading. Prices and provider rules are dated snapshots. This is not financial advice.
Related prediction markets
Prices are catalog snapshots and may have changed. Check each market's rules and observation time.
FDA decision: Vamikibart by Genentech (on or before July 31, 2027)
K 0 contracts
When will Heidi Overton be confirmed as Commissioner of the FDA?
PM $27.9K · K 18.8K contractsWill Heidi Overton be confirmed as FDA Commissioner by December 31?
Kalshi: Will Heidi Overton be confirmed as Commissioner of the Food and Drug Administration before Jan 1, 2027?
Related contracts
Will Heidi Overton be confirmed as FDA Commissioner by November 30?
Kalshi: Will Heidi Overton be confirmed as Commissioner of the Food and Drug Administration before Dec 1, 2026?
Related contracts
Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.
Saved prices; check contract rules.
FDA decision: Ralinepag by United Therapeutics (on or before June 24, 2027)
K 0 contracts
FDA decision: Ulixacaltamide by Praxis Precision Medicines (on or before January 29, 2027)
K 0 contracts
When will the FDA reclassify BPC-157 to Category 1?
PM $4.8K · K 57.1K contractsWill the FDA reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by December 31, 2026?
Kalshi: When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List? (Before 2027)
Same question, fine print differs
Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.
Saved prices; check contract rules.
S&P 2027 year end price range
K 4.1K contractsMarket Insights
Price gaps of 2 pp+
0
Same-question pairs
0
No outcomes on this page have been reviewed as the same question on both platforms yet.
Price differences do not establish arbitrage. Check each pair's review, current order prices, fees and settlement rules.
